Ligand Pharmaceuticals Inc (Symbol: LGND), which makes up 0.29% of the SPDR S&P 400 Mid Cap Growth ETF (Symbol: MDYG), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $4,737,194 worth of LGND, making it the #140 largest holding. The table below details the recent insider buying activity observed at LGND:
LGND — last trade: $123.85 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 03/13/2019 | Jason Aryeh | Director | 202 | $112.51 | $22,727 |
| 03/13/2019 | John L. Higgins | Chief Executive Officer | 2,500 | $114.29 | $285,725 |
And Brinks Co (Symbol: BCO), the #163 largest holding among components of the SPDR S&P 400 Mid Cap Growth ETF (Symbol: MDYG), shows 2 directors and officers as recently filing Form 4's indicating purchases. The ETF holds $4,172,157 worth of BCO, which represents approximately 0.25% of the ETF's total assets at last check. The recent insider buying activity observed at BCO is detailed in the table below:
BCO — last trade: $85.56 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value | Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/13/2019 | Jason Aryeh | Director | 202 | $112.51 | $22,727 | 03/08/2019 | Ronald James Domanico | EVP, Chief Financial Officer | 3,000 | $72.39 | $217,170 |
| 03/13/2019 | John L. Higgins | Chief Executive Officer | 2,500 | $114.29 | $285,725 | 03/11/2019 | Douglas A. Pertz | President and CEO | 10,000 | $72.92 | $729,250 |
10 ETFs With Stocks That Insiders Are Buying »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
